International Stem Cell ISCO
OTC ISCO
$0.30 -0.01 (-3.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

International Stem Cell (ISCO) Price to Earnings (2017 - 2023)

Updated

International Stem Cell's (ISCO) Price to Earnings came in at 8.21 for Q3 2023.

Analysis

International Stem Cell (ISCO) Price to Earnings (2017 - 2023) Analysis & Trends

  • The Q3 2023 figure stands as the highest quarterly Price to Earnings since Q2 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 International Stem Cell 2.40 Mn -1.57 Mn 1.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 8.21
Jun 30, 2017 81.60
Mar 31, 2017 0.67
API Access

International Stem Cell Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ISCO&period=max&api_key=YOUR_API_KEY